A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Hummingbird Bioscience
Hummingbird Bioscience
Bristol-Myers Squibb
Amgen
R-Pharm
R-Pharm
Shanghai Miracogen Inc.
Oscotec Inc.
Shanghai Miracogen Inc.
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
Gilead Sciences
Rakuten Medical, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Memgen, Inc.
Merck Sharp & Dohme LLC
Akeso
OncoC4, Inc.
Shanghai JMT-Bio Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
GlaxoSmithKline
OncoResponse, Inc.
Merck Sharp & Dohme LLC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Bristol-Myers Squibb
Seagen Inc.
Sanofi
Yung Shin Pharm. Ind. Co., Ltd.
Sanofi
Sanofi
AstraZeneca
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi
Sanofi